UCAR Logo

UCAR

ALUCR | PA

Overview

Corporate Details

ISIN(s):
FR0011070457
LEI:
969500K8EPT7JBE7FP45
Country:
France
Address:
10 RUE LOUIS PASTEUR, 92100 BOULOGNE-BILLANCOURT
Sector:
Professional, scientific and technical activities
Industry:
Research and experimental development on natural sciences and engineering

Description

The University Corporation for Atmospheric Research (UCAR) is a nonprofit consortium of over 100 member universities and colleges focused on research and training in atmospheric and Earth system sciences. Its primary role is managing the National Science Foundation National Center for Atmospheric Research (NSF NCAR), a federally funded research and development center. UCAR provides the scientific community with access to advanced research facilities, observing and computing resources, data services, and educational programs. The organization fosters collaboration between academia, government, and the private sector to accelerate scientific discovery in geosciences.

Social Media

Stop Scraping. Start Analyzing.

You're viewing a fraction of the data available for UCAR. Get complete, real-time, and AI-ready data via the API the pros use.

Get Instant API & Bulk Data Access

Filings

You have of free filing views remaining. Upgrade for unlimited access.
Quick Filters:

Filters

Clear
Date Filing Language Size Actions
2022-07-08 16:50
Delisting Announcement
COMMUNIQUE RELATIF A LA MISE EN ŒUVRE DU RETRAIT OBLIGATOIRE VISANT LES ACTIONS…
French 162.7 KB
2022-07-07 10:16
Major Shareholding Notification
Franchissement de seuils
French 201.7 KB
2022-07-05 15:13
Declaration of Voting Results & Voting Rights Announcements
UCAR - Nombre d'actions et de droits de vote au 30 06 2022
French 183.0 KB
2022-06-22 09:02
M&A Activity
MISE A DISPOSITION DE LA NOTE D’INFORMATION EN REPONSE ET DU DOCUMENT « AUTRES …
French 200.2 KB
2022-06-22 09:00
M&A Activity
MISE A DISPOSITION DE LA NOTE D’INFORMATION ET DES INFORMATIONS RELATIVES AUX C…
French 121.8 KB
2022-06-02 09:18
Declaration of Voting Results & Voting Rights Announcements
UCAR - Nombre d'actions et de droits de vote au 31 mai 2022
French 182.3 KB
2022-05-25 16:50
Pre-Annual General Meeting Information
COMMUNIQUE RELATIF AU DEPOT D’UN PROJET DE NOTE EN REPONSE AU PROJET D’OFFRE PU…
French 516.9 KB
2022-05-23 17:50
M&A Activity
UCAR - Accord avec FRANCE PARE BRISE
French 314.5 KB
2022-05-23 10:52
Declaration of Voting Results & Voting Rights Announcements
Franchissement de seuils
French 201.9 KB
2022-05-23 10:50
Major Shareholding Notification
Franchissement de seuils
French 199.0 KB
2022-05-17 19:00
M&A Activity
UCAR - Réalisation de l’acquisition par GOA LCD d’un bloc de contrôle au capita…
French 221.9 KB
2022-05-11 14:55
Declaration of Voting Results & Voting Rights Announcements
UCAR - Nombre d'actions et de droits de vote au 30 avril 2022
French 180.7 KB
2022-04-11 15:30
M&A Activity
UCAR – rapprochement avec le Groupe Cosmobilis – Projet d’OPAS visant les actio…
French 348.7 KB
2022-04-08 09:00
Delisting Announcement
UCAR - Suspension de cours
French 170.0 KB
2022-04-07 21:05
Earnings Release
UCAR - Résultats 2021
French 227.0 KB

Automate Your Workflow. Get a real-time feed of all UCAR filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

No Financial Data Available

Standardized financial statements for the selected period are not yet available.

Need More History? Access decades of standardized financials for UCAR via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
No insider transactions recorded for this company.

Peer Companies

Company Country Ticker View
Circio Holding ASA Logo
Developing circular RNA medicines for gene and cell therapies for hard-to-treat diseases.
Norway CRNA
CIZZLE BIOTECHNOLOGY HOLDINGS PLC Logo
Developing a blood test for early lung cancer detection using a proprietary CIZ1B biomarker.
United Kingdom CIZ
Combigene AB Logo Sweden COMBI
Compugen Ltd. Logo
AI-driven discovery of novel antibody therapies for cancer immunotherapy.
Israel CGEN
Virgin Islands (British) N/A
Cte Group Spolka Akcyjna Logo
Provides B2B services, corporate events, and advanced composite materials R&D.
Poland LPS
Curasight A/S Logo
Developing a theranostics platform for precise diagnosis and targeted radiation therapy for cancer.
Denmark CURAS
Cyclezyme AB Logo
Develops enzymes to recycle PET plastic waste into new high-quality materials.
Sweden CYCLE
Cyxone AB Logo Sweden CYXO
DARWIN AG Logo
AI-powered biotech creating personalized health solutions from biological data for B2C & B2B.
Germany 7V0